JAZMYN PHILLIPS: Open Payments
NPI 1396510822 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 52 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,916 · 2025 $1,904
Food & beverage: $1,710Education: $194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $563 |
| Janssen Biotech, Inc. | 17 | $382 |
| UCB, Inc. | 6 | $256 |
| ABBVIE INC. | 6 | $194 |
| Regeneron Healthcare Solutions, Inc. | 2 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $69 |
| Galderma Laboratories, L.P. | 1 | $28 |
| Journey Medical Corporation | 1 | $22 |
Products named: TREMFYA, Rhapsido, SKYRIZI, DUPIXENT, COSENTYX, Leqselvi, Bimzelx, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
